Celiac disease

I’m deficient, You’re deficient, We’re all deficient? (Part 2)

- In  Part 1 of this article about nutrient deficiencies in the gluten-free population, I posed four critiques and questions that I promised to answer in today’s part 2. Without further ado, here we go… Critique #1 questioned the small sample size of the research. I can’t do anything about that, and there’s not much to be said about it, so ...

Read More »

If there was a ‘Magic’ Gluten-Free Pill

Gluten-eaters often ask me, “Don’t you wish there was some ‘magic’ pill?” This question arises when I have limited choices on a menu, or have to pass the basket of bread without indulging. My response usually includes a “Not really”, with some type of short explanation on why my life doesn’t suck because I’m gluten-free. I can honestly say that I ...

Read More »

ImmunogenX Acquires Celiac Disease Therapy from Alvine Pharmaceuticals

Immunogenx

A therapy for celiac disease is one step closer. ImmunogenX purchased the license for Alvine Pharmaceuticals’ medicine, ALV003, which degrades gluten before it can be digested and absorbed by the intestines. The following press release was distributed by ImmunogenX. “Glutenase for in-vivo gluten degradation is a leading candidate for celiac disease ImmunogenX™, a biopharmaceutical company focused on the diagnosis and ...

Read More »

Infertility, Pre-term Birth and Miscarriage all Linked to Gluten Intolerance

Editor’s Note: The malabsorption resulting from undiagnosed and untreated celiac disease has been well documented in research, but is still little known among physicians. The medical reference Recognizing Celiac Disease contains over 16 pages of reproductive disorders and lists the nutritional deficiencies that cause each. In a recent New York Times article, Can Foods Contribute To Infertility?, Dr. Sheila Crowe, a ...

Read More »

Innovate Biopharmaceuticals Completes License For Late-Stage Celiac Disease Asset From Alba Therapeutics

298549_InnovateBiopharmalogo_300x87[1]

Alba Therapeutics has been working on a therapy for celiac disease the past 8 years. Alba’s therapy, Larazotide Acetate, is the first to reach phase 3 clinical trials, where it will be given to large groups of people. When Alba first contacted us about helping to promote their phase 2 clinical trial, we investigated the therapy’s mechanism and were glad ...

Read More »

Intestinal Gluten Receptor Is Gateway for Celiac Disease

    THURSDAY, July 24 (HealthDay News) — Researchers believe they have finally answered a basic question about the cause of celiac disease — where in the body does the wheat protein gluten enter one’s system? A study published in the July issue of Gastroenterology identifies the CXCR3 receptor in the intestine as a gluten gateway. When people with celiac ...

Read More »

Investigation of gluten sensitivity requires anti-gliadin antibody testing.

The news release below is timely because anti-gliadin antibody blood tests are losing ground while the reality of gluten sensitivity looms far larger than is now appreciated by many doctors!  These blood tests are absolutely necessary to investigate health problems caused by gluten itself, yet they are being dismissed by doctors who look only to diagnosing celiac disease. Positive anti-gliadin ...

Read More »

Is Low Stomach Acid Making You Sick??

Low stomach acid is common in celiac disease and dermatitis herpetiformis.  It is also common in the general population, as well, affecting 50% of people age 60 years and about 80% by age 85 years.  Nevertheless, low stomach acid is not generally looked for as a cause of acute and chronic disorders that rob health with far-reaching effects. Is Low ...

Read More »

Is the Media Fueling the Gluten free, Casein Free Autism Controversy?

The debate about autism and the effectiveness of the gluten-free, casein-free diet continues – this time due to irresponsible reporting of the mainstream news media who seem to have chosen sensationalism over objective journalism when covering an important medical paper on gastrointestinal disorders in autism. This week, a panel of medical experts led by Timothy Buie, MD at Harvard Medical ...

Read More »